Prometa Pharmacotherapy for Methamphetamine Dependence

NCT00260481 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Drug Abuse
Drug Dependence

Interventions

DRUG: Prometa
DRUG: Placebo

Sponsor

University of California, Los Angeles